Athanor Capital, LP Amgen Inc Transaction History

Athanor Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $377,150 - $449,118	-1,743 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $408,994 - $454,835	1,743 New	1,743 $443,000
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $674,288 - $894,290	-3,700 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $245,973 - $316,160	-1,300 Reduced 26.0%	3,700 $892,000
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $870,550 - $1.04 Million	5,000 New	5,000 $968,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.